Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Alzheimer's DiseaseDementia
Interventions
DRUG

Drug: EVP-6124

DRUG

Placebo

Trial Locations (81)

Unknown

Tucson

Little Rock

Culver City

Downey

Los Alamitos

Los Angeles

Oceanside

Orange

Norwich

Bradenton

Gainesville

Hallandale

Hialeah

Jacksonville

Leesburg

Miami

Sarasota

Sunrise

West Palm Beach

Atlanta

Elk Grove Village

Springfield

Newton

Hattiesburg

Albuquerque

Albany

Cedarhurst

New Hyde Park

New York

Staten Island

Charlotte

Durham

Shaker Heights

Oklahoma City

Abington

Jenkintown

Plains

East Providence

Houston

Salt Lake City

Charlottesville

Richland

Buenos Aires

Rosario

Santa Fe

Box Hill

Caulfield South

Halifax

London

Québec

Brno

Choceň

Hradec Králové

Prague

Richnov Nad Kneznou

Bordeaux

Caen

Paris

Homburg

Mittweida

München

Westerstede

Ancona

Milan

Saltillo

Amsterdam

S'Hertogenbosch

The Hague

Durban

Bellville

George

Incheon

Seoul

Madrid

Salamanca

West End

Bath

Glasgow

Isleworth

Northampton

Penarth

Sponsors
All Listed Sponsors
lead

FORUM Pharmaceuticals Inc

INDUSTRY